Mindfulness Techniques Can Help Treat Opioid Use Disorder, Study Finds

HealthDay (5/8, Miller) reports, “Using mindfulness to help people trying to overcome opioid addiction can boost their odds of continuing treatment, new research shows.” Researchers “found that supplementing standard opioid addiction treatment with an intervention called Mindfulness Oriented Recovery Enhancement (MORE) cut dropout rates by 59% and relapses by 42%.” The results were published in JAMA Psychiatry.

Related Links:

— “How Mindfulness Could Help Folks Quit Opioids,”Carole Tanzer Miller, HealthDay, May 8, 2024

Referrals For Eating Disorder Treatment Spiked During COVID-19 Pandemic, Researchers Say

Healio (5/7, Young) reports, “Referrals for eating disorder treatment spiked during the COVID-19 pandemic, with patients more likely to present with eating disorder as a primary diagnosis, according to a poster at the American Psychiatric Association annual meeting.” According to the researchers, “the average number of referrals per month spiked from 3.67 pre-pandemic to 8.56 during the pandemic.”

Related Links:

— “Eating disorder referrals spiked during COVID-19 pandemic,”Kate Young, Healio, May 7, 2024

Researchers Highlight Need For Greater Access To Trauma-Focused Care For Incarcerated Women

Healio (5/7, Young) reports, “A poster presented at the American Psychiatric Association annual meeting highlighted the need for greater access and engagement in trauma-focused care for incarcerated women, including peer-led interventions.” In a study of such individuals, “all 51 participants reported experiencing at least one traumatic event prior to incarceration, with 98% reporting physical and emotional abuse. Symptoms of PTSD were present in 96% of participants, and 43% had a history of drug-related charges. Of those selected for in-depth interviews, 87.5% reported substance use before incarceration.”

Related Links:

— “‘Very clear’ need, desire for trauma-focused treatment in women’s prisons,”Kate Young , Healio, May 7, 2024

People With Two Copies Of APOE4 Gene Variant Have Distinct Genetic Form Of Alzheimer’s, Study Suggests

The New York Times (5/6, Belluck ) reports, “Scientists are proposing a new way of understanding the genetics of Alzheimer’s that would mean that up to a fifth of patients would be considered to have a genetically caused form of the disease.” The concept “involves a gene variant called APOE4. Scientists have long known that inheriting one copy of the variant increases the risk of developing Alzheimer’s, and that people with two copies, inherited from each parent, have vastly increased risk.”

The AP (5/6, Neergaard ) reports that now, “research published Monday suggests that for people who carry not one but two copies of the gene, it’s more than a risk factor, it’s an underlying cause of the mind-robbing disease.” Additionally, for these patients, “symptoms can begin seven to 10 years sooner than in other older adults who develop Alzheimer’s.” Around “15% of Alzheimer’s patients carry two copies of APOE4.”

Reuters (5/6, Steenhuysen) reports, “The reclassification could change Alzheimer’s research, diagnosis and approaches to treatment, according to the researchers, whose study was published in the journal Nature Medicine.”

Related Links:

— “The New York Times (requires login and subscription)

Clinicians More Often Assigned Psychotic And Childhood Disorder Diagnoses To Black Vs. White Patients, Literature Review Finds

Healio (5/6, Young) reports, “A literature review revealed that clinicians more often assigned psychotic and childhood disorder diagnoses to Black vs. white patients, according to a poster presented at the American Psychiatric Association annual meeting.” Investigators “found that clinicians more often assigned psychotic and childhood disorder diagnoses to Black patients vs. white patients, and that white patients were more likely diagnosed with adjustment disorder or ADHD.” The “researchers wrote that ‘unconscious bias and underlying societal structures’ may lead to Black patients receiving more severe diagnoses than their white counterparts.”

Related Links:

— “More research needed on racial bias in diagnosing oppositional defiant disorder,”Kate Young, Healio, May 6, 2024

Study Finds Consuming Spoonful Of Olive Oil Daily Lowers Risk Of Dementia-Related Death

CNN (5/6, Rogers ) reports, “A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists” published in JAMA Network Open. Among “more than 92,000 adults observed over 28 years, consuming at least 7 grams – a bit over half a tablespoon – of olive oil daily was linked with a 28% lower risk of dementia-related death, compared with those who never or rarely ate olive oil, found the study published Monday.”

MedPage Today (5/6, George ) says, “The relationship remained significant after adjusting for diet quality, including adherence to a Mediterranean diet, and after accounting for APOE4 gene status, the researchers reported.” Additionally, “replacing 5 g (about 1 teaspoon) of margarine and mayonnaise with the equivalent amount of olive oil daily was associated with an 8-14% lower risk of dementia mortality, they noted. Substitutions for other vegetable oils or butter were not significant.”

Related Links:

MedPage Today (requires login and subscription)

Study Reveals Growing Disparities In Child Death Rates Across Racial, Ethnic Groups

The New York Times (5/4, Baumgaertner ) reported, “Thanks to advancements in medicine and insurance, mortality rates for children in the United States had been shrinking for decades. But last year, researchers uncovered a worrisome reversal: The child death rate was rising.” Now, “a new study, published Saturday in The Journal of the American Medical Association, revealed growing disparities in child death rates across racial and ethnic groups.” Specifically, “Black and Native American youths ages 1 to 19 died at significantly higher rates than white youths – predominantly from injuries such as car accidents, homicides and suicides.”

Related Links:

— “The New York Times (requires login and subscription)

Drug Overdoses, Gun Violence Accounted For 23% Of Parental Loss In 2020, Study Finds

CNN (5/4, McPhillips ) reported, “Deaths from drug overdoses and firearm-related injuries have reached record levels in the United States in recent years, and it’s created a ‘double burden’ for children who face an increased risk of losing their parents and of dying themselves, according to the authors of a new study” published in JAMA. Over “1 million children have lost a parent to a fatal drug overdose or gun violence over the past two decades, according to the study, published Saturday…and the burden has increased significantly over time.” Almost “100,000 children lost parents to a drug overdose or gun violence in 2020 alone – almost three times more than in 1999, the study found. These two causes of death accounted for 23% of all parental loss in 2020, nearly double the share from 1999.”

Related Links:

— “Nearly 100,000 children in the US lost a parent to a drug overdose or gun violence in 2020, study finds,”Deidre McPhillips, CNN, May 4, 2024

Still Not Enough Evidence To Support Use Of Pharmacogenetic Tests In Treatment Of Depression, APA Workgroup Recommends

Psychiatric News (5/3) reports, “There is still not enough evidence to support the use of pharmacogenetic tests in the treatment of depression, according to updated recommendations from APA’s Workgroup on Biomarkers and Novel Treatments.” For the recommendations published in AJP in Advance, “the workgroup examined data from 11 pharmacogenetic clinical trials conducted between 2017 and 2022, as well as six meta-analyses that combined individual results.” Workgroup members wrote in the updated recommendations, “Despite expert opinions, warnings, and policy statements regarding their limitations for predicting antidepressant treatment response, the popularity of [pharmacogenetic] testing products has grown, with at least 35 U.S. commercial entities providing them by 2020.”

Related Links:

— “Evidence Base for Pharmacogenetic Tests Still Lacking, APA Workgroup Finds, Psychiatric News, May 3, 2024

Serious Mental Illness Tied To Twofold Increased Risk For Comorbid Physical Illness, Meta-Analysis Shows

Medscape (5/3, Bender, Subscription Publication) reports, “Serious mental illness (SMI), including bipolar disorder or schizophrenia spectrum disorders, is associated with a twofold increased risk for comorbid physical illness, results of a new meta-analysis showed.” Researchers “conducted a meta-analysis of 82 observational studies comprising 1.6 million individuals with SMI and 13.2 million control subjects to determine the risk for physical or psychiatric multimorbidity.”The results were published in The Lancet Psychiatry.

Related Links:

Medscape (requires login and subscription)